Table 1.
Level of Risk | PSA Level (ng/mL) | Gleason Score | Clinical Stage | ||
---|---|---|---|---|---|
Low risk | <10 | and | ≤6 | and | T1–T2a |
Intermediate risk | 10–20 | or | 7 | or | T2b |
High risk | >20 | or | 8–10 | or | ≥T2c |
Level of Risk | PSA Level (ng/mL) | Gleason Score | Clinical Stage | ||
---|---|---|---|---|---|
Low risk | <10 | and | ≤6 | and | T1–T2a |
Intermediate risk | 10–20 | or | 7 | or | T2b |
High risk | >20 | or | 8–10 | or | ≥T2c |